Clofazimine Pricing Report ​2024​: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data

Clofazimine Pricing Report ​2024​: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data

Report Format: PDF+Excel | Report ID: SR112024A23266
Buy Now

Clofazimine Prices June 2023

Product
Category Region Price
Clofazimine Pharma API APAC 514498 USD/MT


The price of clofazimine in the APAC reached 514498 USD/MT in June 2023.

Clofazimine Price Trend, Market Analysis, and News

IMARC’s newly published report, titled “Clofazimine Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data,” offers an in-depth analysis of clofazimine pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.

It encompasses an in-depth review of spot prices at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of clofazimine price trend across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.

The report examines the elements influencing clofazimine price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.

Clofazimine Price Trend

Clofazimine Market Analysis

The global clofazimine market size reached US$ 2.1 Billion in 2023. By 2032, IMARC Group expects the market to reach US$ 2.8 Billion, at a projected CAGR of 3.15% during 2023-2032.

  • Clofazimine has shown efficacy against resistant bacteria, which is one of the major drivers of its market expansion. There has been a rise in antibiotic-resistant strains of bacteria, such as multi-drug-resistant tuberculosis (MDR-TB), and certain forms of leprosy, which has created the need for the development and deployment of drugs that can effectively combat these infections. Globally, MDR/RR-TB estimated 160,000 deaths in 2022. Also, the estimated proportion of new TB cases with MDR/RR-TB reached 3.3% in the same year. This has increased the necessity of drugs like clofazimine that are effective in treating patients with these conditions. This drug operates by binding to bacterial deoxyribonucleic acid (DNA) and inhibiting replication, leading to bacterial cell death. This mechanism is particularly effective against mycobacteria, including those resistant to first-line antibiotics.
  • Clinical trials and real-world use have also demonstrated the drug’s ability to reduce bacterial loads in patients with MDR-TB, often as part of a combination therapy. Its use in leprosy treatment has a long history of success, reducing disease transmission and preventing relapse. By effectively treating resistant infections, it plays a crucial role in global health efforts to manage and control antibiotic resistance.
  • Government and policy support for the use of this drug in national treatment programs is a significant factor in its widespread adoption. Many countries, like India are including this drug in their national guidelines for treating leprosy and tuberculosis. The World Health Organization (WHO) reported that leprosy was endemic in several Indian states and union territories, with an annual case detection rate of 4.56 per 10,000 population. The country reported more than 1,25,000 new patients of leprosy every year. To counter that, the Government of India (GOI) launched the National Leprosy Eradication Programme (NLEP). It aims to eliminate leprosy in each of the districts by 2030. These government-funded health programs and subsidies help lower the cost barriers for patients, making the drug more accessible.

Clofazimine News

The report covers the latest developments, updates, and trends impacting the global clofazimine market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in clofazimine production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the clofazimine price trend.

Latest developments in the clofazimine industry:

  • In April 2024, MannKind Corporation announced that the U.S. Food and Drug Administration (FDA) has cleared the company’s Investigational New Drug (IND) application for MNKD-101 (Clofazimine Inhalation Suspension), enabling the initiation of a Phase 3 study for the treatment of nontuberculous mycobacterial (NTM) lung disease. Oral clofazimine has been utilized as a treatment option for patients living with NTM lung disease and the company believes that by reducing the dose and administering it directly to the lung, they can demonstrate improved dosing, tolerability and safety.
  • In January 2024, the central government of India approved a new treatment regimen for leprosy in the country from April 1, 2025. The country aims to create a leprosy-free India by 2027. The Ministry of Health and Family Welfare has taken a significant step in the multi-drug therapy (MDT) treatment regimen for leprosy patients in India. The WHO has been providing MDT free of cost, which is donated via an agreement with Novartis.

Product Description

Clofazimine is a phenazine dye with antimycobacterial properties. It is utilized to treat leprosy and certain mycobacterial infections, including multi-drug-resistant tuberculosis. It binds to bacterial deoxyribonucleic acid (DNA), disrupting replication and leading to bacterial death. It is a lipophilic compound with strong anti-inflammatory attributes and is available in oral capsule form composed of clofazimine, gelatin, and other excipients. It finds application in the treatment of leprosy, multi-drug-resistant tuberculosis, Mycobacterium avium complex, Crohn's disease, Buruli ulcer, lupus, severe acne, erythrasma, and coronavirus (COVID-19).

The drug offers several benefits, such as effectiveness against resistant bacterial strains, a long half-life, reduced inflammation, a low likelihood of resistance development, minimal drug interactions, convenient oral administration, improved quality of life, cost-effectiveness, and suitability for long-term therapy. Moreover, it is lauded for its high efficacy, versatile therapeutic uses, prolonged antibacterial effect, anti-inflammatory properties, low resistance profile, and compatibility.

Regional Coverage

The report provides a detailed analysis of the clofazimine market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the clofazimine price trend. 

Global Clofazimine Price

The report offers a holistic view of the global clofazimine pricing trends, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level.

Europe Clofazimine Price

European clofazimine prices are examined, highlighting the market-specific influences in the region, such as stringent environmental regulations, the competitive landscape, and import-export imbalances that significantly affect pricing structures.

This analysis can be extended to include detailed clofazimine price information for a comprehensive list of countries.

Region Countries Covered
Europe Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries.


North America Clofazimine Price

The analysis of clofazimine prices in North America delves into the regional industry dynamics, encompassing the impact of local production capacities and the trade flows between North America and other significant global markets.

Specific data on clofazimine prices within the United States and Canada can also be provided.

Region Countries Covered
North America United States and Canada


Middle East and Africa Clofazimine Price

The report explores the clofazimine pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.

In addition to region-wise data, information on clofazimine prices for countries can also be provided.

Region Countries Covered
Middle East & Africa Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries.


Asia Pacific Clofazimine Price

The clofazimine pricing trends in Asia Pacific are examined, reflecting the role of the region as a major global production hub and consumer market, with price dynamics heavily influenced by supply chain efficiencies, regional demand surges, and policy shifts in major economies.

This analysis can be further extended to include detailed clofazimine prices for a comprehensive list of countries within the region.

Region Countries Covered
Asia Pacific China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries.


Latin America Clofazimine Price

The analysis of clofazimine prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.

This comprehensive review can be extended to include specific countries within the region.

Region Countries Covered
Latin America Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries.


Report Coverage

Key Attributes Details
Product Name Clofazimine
Report Features Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Price Analysis, and Segment-Wise Assessment.
Currency/Units US$ (Data can also be provided in local currency) or Metric Tons
Region/Countries Covered The current coverage includes analysis at the global and regional levels only. 
 
Based on your requirements, we can also customize the report and provide specific information for the following countries: 
 
Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand*
 
Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece* 
 
North America: United States and Canada

Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru*

Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco*

*The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client.
Information Covered for Key Suppliers
  • Company Overview
  • Business Description
  • Product Portfolio
  • Recent Trends and Developments
Customization Scope The report can be customized as per the requirements of the customer
Report Price and Purchase Option

Plan A: Monthly Updates - Annual Subscription

  • Scope
    • Historical Data for the Current Month
    • Forecast for Next Month
  • Total Deliverables Per Year: 12 (One Per Month)
  • Includes: One PDF and Excel datasheet per month, Post Purchase Analyst Support throughout the year

Plan B: Quarterly Updates - Annual Subscription

  • Scope
    • Historical Data for the Current Quarter
    • Forecast for Next Quarter
  • Total Deliverables Per Year: 4 (One Per Quarter)
  • Includes: One PDF and Excel datasheet per Quarter, Post Purchase Analyst Support throughout the year

Plan C: Biannually Updates - Annual Subscription

  • Scope
    • Historical Data for the Current Half
    • Forecast for the Next Half
  • Total Deliverables Per Year: 2 (One Per 6 Months)
  • Includes: One PDF and Excel datasheet per Half, Post Purchase Analyst Support throughout the year
Post-Sale Analyst Support  360-degree analyst support after report delivery
Delivery Format PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) 


Key Benefits for Stakeholders:

  • IMARC’s report presents a detailed analysis of clofazimine pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
  • The study examines factors affecting clofazimine price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
  • The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
  • IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights, ensuring they remain at the forefront of the clofazimine industry.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Clofazimine Pricing Report ​2024​: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data
Purchase options
For 2 Deliverables, Billed Annually

For 4 Deliverables, Billed Annually

For 12 Deliverables, Billed Annually


Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More